Interobserver variability in the evaluation of mismatch repair protein immunostaining

Human Pathology

Volumn 41, Issue 10, 2010, Pages 1387-1396

  Klarskov, Louise ^a   Ladelund, Steen ^a   Holck, Susanne ^a   Roenlund, Karina ^b   Lindebjerg, Jan ^b   Elebro, Jacob ^c   Halvarsson, Britta ^d   Von Salomé, Jenny ^e   Bernstein, Inge ^a   Nilbert, Mef ^a,f  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LILLEBAELT HOSPITAL   (Denmark)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d Aleris Medilab ^*  (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f LUND UNIVERSITY   (Sweden)

Author keywords

HNPCC; Immunohistochemistry; Lynch Syndrome; MMR; Reliability

Indexed keywords

MISMATCH REPAIR PROTEIN; ADENOSINE TRIPHOSPHATASE; DNA BINDING PROTEIN; G-T MISMATCH-BINDING PROTEIN; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; NUCLEAR PROTEIN; PMS2 PROTEIN, HUMAN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN MSH2; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; AGED; ARTICLE; COLORECTAL CANCER; CONSENSUS; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC VARIABILITY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; RESIDENT; GENETICS; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; METABOLISM; MIDDLE AGED; MISMATCH REPAIR; MUTATION; OBSERVER VARIATION; VERY ELDERLY; YOUNG ADULT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATASES; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; OBSERVER VARIATION; YOUNG ADULT;

EID: 77957146724     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.03.003     Document Type: Article

References (21)

1. Jass J.R. Origins of familial cancer: histopathological perspectives J Clin Pathol 50 1997 892 895
2. Jenkins M.A, Hayashi S, and O'Shea A.M., et al. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study Gastroenterology 133 2007 48 56
3. Engel C, Forberg J, and Holinski-Feder E. Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer Int J Cancer 118 2006 115 122
4. Hampel H, Frankel W.L, and Martin E. Feasibility of screening for Lynch syndrome among patients with colorectal cancer J Clin Oncol 26 2008 5783 5788
5. Shia J, Tang L.H, and Vakiani E. Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel Am J Surg Pathol 33 2009 1639 1645
6. Boland C.R. Evolution of the nomenclature for the hereditary colorectal cancer syndromes Fam Cancer 4 2005 211 218
7. Halvarsson B, Lindblom A, Rambech E, Lagerstedt K, and Nilbert M. Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer? Virchows Arch 444 2004 135 141 (Pubitemid 38315290)
8. Shia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry J Mol Diagn 10 2008 293 300
9. Plaschke J, Kruger S, Pistorius S, Theissig F, Saeger H.D, and Schackert H.K. Involvement of hMSH6 in the development of hereditary and sporadic colorectal cancer revealed by immunostaining is based on germline mutations, but rarely on somatic inactivation Int J Cancer 97 2002 643 648
10. Bertagnolli M.M, Niedzwiecki D, and Compton C.C. Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage iii colon cancer: cancer and leukemia group B protocol 89803 J Clin Oncol 27 2009 1814 1821
11. Vilar E, and Gruber S.B. Microsatellite instability in colorectal cancer-the stable evidence Nat Rev Clin Oncol 7 2010 153 162
12. Shia J, Ellis N.A, and Klimstra D.S. The utility of immunohistochemical detection of DNA mismatch repair gene proteins Virchows Arch 445 2004 431 441
13. Shia J, Klimstra D.S, and Nafa K. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms Am J Surg Pathol 29 2005 96 104
14. Muller W, Burgart L.J, and Krause-Paulus R. The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)-results of an international collaborative study Fam Cancer 1 2001 87 92
15. Overbeek L.I, Ligtenberg M.J, and Willems R.W. Interpretation of immunohistochemistry for mismatch repair proteins is only reliable in a specialized setting Am J Surg Pathol 32 2008 1246 1251
16. Jass J.R. Role of the pathologist in the diagnosis of hereditary non-polyposis colorectal cancer Dis Markers 20 2004 215 224
17. Muller A, Giuffre G, and Edmonston T.B. Challenges and pitfalls in HNPCC screening by microsatellite analysis and immunohistochemistry J Mol Diagn 6 2004 308 315
18. Uebersax J.S, and Grove W.M. A latent trait finite mixture model for the analysis of rating agreement Biometrics 49 1993 823 835
19. Landis J.R, and Koch G.G. The measurement of observer agreement for categorical data Biometrics 33 1977 159 174
20. Mangold E, Pagenstecher C, and Friedl W. Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining J Pathol 207 2005 385 395
21. Boland C.R, Koi M, Chang D.K, and Carethers J.M. The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside Fam Cancer 7 2008 41 52